Metastasis-associated protein 1 drives tumor cell migration and invasion through transcriptional repression of RING finger protein 144A

Journal of Biological Chemistry

Volumn 287, Issue 8, 2012, Pages 5615-5626

  Marzook, Hezlin ^a   Li, Da Qiang ^b   Nair, Vasudha S ^b   Mudvari, Prakriti ^b   Reddy, Sirigiri Divijendra Natha ^b   Pakala, Suresh B ^b   Santhoshkumar, T R ^a   Pillai, M Radhakrishna ^a   Kumar, Rakesh ^a,b  

^a RAJIV GANDHI CENTRE FOR BIOTECHNOLOGY   (India)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER CELLS; CCAAT/ENHANCER-BINDING PROTEINS; CELL MIGRATION; COREPRESSORS; EXPRESSION LEVELS; FUNCTIONAL ASPECTS; HISTONE DEACETYLASES; HUMAN CANCER; IN-VIVO; INVERSE CORRELATION; METASTATIC CANCER CELLS; MICROARRAY DATA SETS; MODEL SYSTEM; OVER-EXPRESSION; RING FINGER; SMALL INTERFERING RNA; TRANSCRIPTIONAL REPRESSION; TUMOR CELL MIGRATION; TUMOR INVASION; TUMOR PROGRESSIONS; UBIQUITIN LIGASES;

CELLS; DATA REDUCTION; DISEASES; GENE EXPRESSION; PATHOLOGY; TUMORS;

PROTEINS;

CCAAT ENHANCER BINDING PROTEIN ALPHA; HISTONE DEACETYLASE 2; METASTASIS ASSOCIATED PROTEIN 1; ONCOPROTEIN; RING FINGER PROTEIN; RING FINGER PROTEIN 144A; SMALL INTERFERING RNA; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CANCER MODEL; CELL MIGRATION; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VIVO STUDY; METASTASIS; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; TRANSCRIPTION REGULATION;

ANIMALS; CARRIER PROTEINS; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CELL LINE, TUMOR; CELL MOVEMENT; COMPUTATIONAL BIOLOGY; GENE SILENCING; HELA CELLS; HISTONE DEACETYLASE 2; HISTONE DEACETYLASES; HUMANS; MICE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROMOTER REGIONS, GENETIC; REPRESSOR PROTEINS; RNA, MESSENGER; TRANSCRIPTION, GENETIC; UBIQUITIN-PROTEIN LIGASES;

EID: 84863181098     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.314088     Document Type: Article

References (50)

1. Valastyan, S., and Weinberg, R. A. (2011) Tumor metastasis: molecular insights and evolving paradigms. Cell 147, 275-292
2. Gupta, G. P., and Massagué, J. (2006) Cancer metastasis: building a framework. Cell 127, 679-695 (Pubitemid 44781029)
3. Steeg, P. S. (2006) Tumor metastasis: mechanistic insights and clinical challenges. Nat. Med. 12, 895-904
4. Wang, W., Eddy, R., and Condeelis, J. (2007) The cofilin pathway in breast cancer invasion and metastasis. Nat. Rev. Cancer 7, 429-440 (Pubitemid 46809168)
5. Toh, Y., and Nicolson, G. L. (2009) The role of the MTA family and their encoded proteins in human cancers: molecular functions and clinical implications. Clin. Exp. Metastasis 26, 215-227
6. Kumar, R., Wang, R. A., Mazumdar, A., Talukder, A. H., Mandal, M., Yang, Z., Bagheri-Yarmand, R., Sahin, A., Hortobagyi, G., Adam, L., Barnes, C. J., and Vadlamudi, R. K. (2002) A naturally occurring MTA1 variant sequesters oestrogen receptor-α in the cytoplasm. Nature 418, 654-657
7. Toh, Y., Pencil, S. D., and Nicolson, G. L. (1994) A novel candidate metastasis-associated gene, mta1, differentially expressed in highly metastatic mammary adenocarcinoma cell lines. cDNA cloning, expression, and protein analyses. J. Biol. Chem. 269, 22958-22963
8. Kumar, R., Wang, R. A., and Bagheri-Yarmand, R. (2003) Emerging roles of MTA family members in human cancers. Semin Oncol. 30, 30-37 (Pubitemid 37433394)
9. Manavathi, B., Singh, K., and Kumar, R. (2007) MTA family of coregulators in nuclear receptor biology and pathology. Nucl. Recept. Signal 5, e010
10. Mahoney, M. G., Simpson, A., Jost, M., Noé, M., Kari, C., Pepe, D., Choi, Y. W., Uitto, J., and Rodeck, U. (2002) Metastasis-associated protein (MTA)1 enhances migration, invasion, and anchorage-independent survival of immortalized human keratinocytes. Oncogene 21, 2161-2170 (Pubitemid 34311370)
11. Nicolson, G. L., Nawa, A., Toh, Y., Taniguchi, S., Nishimori, K., and Moustafa, A. (2003) Tumor metastasis-associated human MTA1 gene and its MTA1 protein product: role in epithelial cancer cell invasion, proliferation, and nuclear regulation. Clin. Exp. Metastasis 20, 19-24 (Pubitemid 36308132)
12. Hofer, M. D., Menke, A., Genze, F., Gierschik, P., and Giehl, K. (2004) Expression of MTA1 promotes motility and invasiveness of PANC-1 pancreatic carcinoma cells. Br. J. Cancer 90, 455-462 (Pubitemid 38250645)
13. Qian, H., Yu, J., Li, Y., Wang, H., Song, C., Zhang, X., Liang, X., Fu, M., and Lin, C. (2007) RNA interference of metastasis-associated gene 1 inhibits metastasis of B16F10 melanoma cells in a C57BL/6 mouse model. Biol. Cell. 99, 573-581 (Pubitemid 47543315)
14. Kai, L., Wang, J., Ivanovic, M., Chung, Y. T., Laskin, W. B., Schulze-Hoepfner, F., Mirochnik, Y., Satcher, R. L., Jr., and Levenson, A. S. (2011) Targeting prostate cancer angiogenesis through metastasis-associated protein 1 (MTA1). Prostate 71, 268-280
15. Jiang, Q., Zhang, H., and Zhang, P. (2011) ShRNA-mediated gene silencing of MTA1 influenced on protein expression of ER α, MMP-9, CyclinD1 and invasiveness, proliferation in breast cancer cell lines MDA-MB-231 and MCF-7 in vitro. J. Exp. Clin. Cancer Res. 30, 60
16. Ghanta, K. S., Li, D. Q., Eswaran, J., and Kumar, R. (2011) Gene profiling of MTA1 identifies novel gene targets and functions. PLoS One 6, e17135
17. Li, D. Q., Pakala, S. B., Reddy, S. D., Ohshiro, K., Peng, S. H., Lian, Y., Fu, S. W., and Kumar, R. (2010) Revelation of p53-independent function of MTA1 in DNA damage response via modulation of the p21 WAF1-proliferating cell nuclear antigen pathway. J. Biol. Chem. 285, 10044-10052
18. Joazeiro, C. A., and Weissman, A. M. (2000) RING finger proteins: mediators of ubiquitin ligase activity. Cell 102, 549-552
19. Lipkowitz, S., and Weissman, A. M. (2011) RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis. Nat. Rev. Cancer 11, 629-643
20. Manavathi, B., Peng, S., Rayala, S. K., Talukder, A. H., Wang, M. H., Wang, R. A., Balasenthil, S., Agarwal, N., Frishman, L. J., and Kumar, R. (2007) Repression of Six3 by a corepressor regulates rhodopsin expression. Proc. Natl. Acad. Sci. U.S.A. 104, 13128-13133 (Pubitemid 351737604)
21. Santner, S. J., Dawson, P. J., Tait, L., Soule, H. D., Eliason, J., Mohamed, A. N., Wolman, S. R., Heppner, G. H., and Miller, F. R. (2001) Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells. Breast Cancer Res. Treat. 65, 101-110 (Pubitemid 32193613)
22. Dawson, P. J., Wolman, S. R., Tait, L., Heppner, G. H., and Miller, F. R. (1996) MCF10AT: a model for the evolution of cancer from proliferative breast disease. Am. J. Pathol. 148, 313-319
23. Miller, F. R., Santner, S. J., Tait, L., and Dawson, P. J. (2000) MCF10DCIS.com xenograft model of human comedo ductal carcinoma in situ. J. Natl. Cancer Inst. 92, 1185-1186
24. Hurst, D. R., Xie, Y., Edmonds, M. D., and Welch, D. R. (2009) Multiple forms of BRMS1 are differentially expressed in the MCF10 isogenic breast cancer progression model. Clin. Exp. Metastasis 26, 89-96
25. Soule, H. D., Maloney, T. M., Wolman, S. R., Peterson, W. D., Jr., Brenz, R., McGrath, C. M., Russo, J., Pauley, R. J., Jones, R. F., and Brooks, S. C. (1990) Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res. 50, 6075-6086 (Pubitemid 20331424)
26. Mazumdar, A., Wang, R. A., Mishra, S. K., Adam, L., Bagheri-Yarmand, R., Mandal, M., Vadlamudi, R. K., and Kumar, R. (2001) Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor. Nat. Cell Biol. 3, 30-37 (Pubitemid 32114829)
27. Dignam, J. D., Lebovitz, R. M., and Roeder, R. G. (1983) Accurate transcription initiation byRNApolymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11, 1475-1489
28. Li, D. Q., Ohshiro, K., Khan, M. N., and Kumar, R. (2010) Requirement of MTA1 in ATR-mediated DNA damage checkpoint function. J. Biol. Chem. 285, 19802-19812
29. Iwamoto, T., Bianchini, G., Booser, D., Qi, Y., Coutant, C., Shiang, C. Y., Santarpia, L., Matsuoka, J., Hortobagyi, G. N., Symmans, W. F., Holmes, F. A., O'Shaughnessy, J., Hellerstedt, B., Pippen, J., Andre, F., Simon, R., and Pusztai, L. (2011) Gene pathways associated with prognosis and chemotherapy sensitivity in molecular subtypes of breast cancer. J. Natl. Cancer Inst. 103, 264-272
30. Miller, L. D., Smeds, J., George, J., Vega, V. B., Vergara, L., Ploner, A., Pawitan, Y., Hall, P., Klaar, S., Liu, E. T., and Bergh, J. (2005) An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc. Natl. Acad. Sci. U.S.A. 102, 13550-13555 (Pubitemid 41420886)
31. Reddy, S. D., Pakala, S. B., Ohshiro, K., Rayala, S. K., and Kumar, R. (2009) MicroRNA-661, a c/EBPα target, inhibits metastatic tumor antigen 1 and regulates its functions. Cancer Res. 69, 5639-5642
32. Khaleque, M. A., Bharti, A., Gong, J., Gray, P. J., Sachdev, V., Ciocca, D. R., Stati, A., Fanelli, M., and Calderwood, S. K. (2008) Heat shock factor 1 represses estrogen-dependent transcription through association with MTA1. Oncogene 27, 1886-1893 (Pubitemid 351430827)
33. Sobell, H. M. (1985) Actinomycin and DNA transcription. Proc. Natl. Acad. Sci. U.S.A. 82, 5328-5331
34. Flamée, P. A. (1985) The action of actinomycin D on the transcription of T7 coliphage DNA by Escherichia coli RNA polymerase. Biochem. J. 230, 557-560
35. Li, D. Q., Pakala, S. B., Reddy, S. D., Ohshiro, K., Zhang, J. X., Wang, L., Zhang, Y., Moreno de Alborán, I., Pillai, M. R., Eswaran, J., and Kumar, R. (2011) Bidirectional autoregulatory mechanism of metastasis-associated protein 1-alternative reading frame pathway in oncogenesis. Proc. Natl. Acad. Sci. U.S.A. 108, 8791-8796
36. Manavathi, B., and Kumar, R. (2007) Metastasis tumor antigens, an emerging family of multifaceted master coregulators. J. Biol. Chem. 282, 1529-1533 (Pubitemid 47076673)
37. Duan, H., Heckman, C. A., and Boxer, L. M. (2005) Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14; 18) lymphomas. Mol. Cell Biol. 25, 1608-1619 (Pubitemid 40280131)
38. Qian, H., Lu, N., Xue, L., Liang, X., Zhang, X., Fu, M., Xie, Y., Zhan, Q., Liu, Z., and Lin, C. (2005) Reduced MTA1 expression by RNAi inhibits in vitro invasion and migration of esophageal squamous cell carcinoma cell line. Clin. Exp. Metastasis 22, 653-662 (Pubitemid 44259526)
39. Rao, Y., Wang, H., Fan, L., and Chen, G. (2011) Silencing MTA1 by RNAi reverses adhesion, migration and invasiveness of cervical cancer cells (SiHa) via altered expression of p53, and E-cadherin/β-catenin complex. J. Huazhong. Univ. Sci. Technolog. Med. Sci. 31, 1-9
40. Wicki, A., Lehembre, F., Wick, N., Hantusch, B., Kerjaschki, D., and Christofori, G. (2006) Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton. Cancer Cell 9, 261-272
41. Didier, C., Broday, L., Bhoumik, A., Israeli, S., Takahashi, S., Nakayama, K., Thomas, S. M., Turner, C. E., Henderson, S., Sabe, H., and Ronai, Z. (2003) RNF5, a RING finger protein that regulates cell motility by targeting paxillin ubiquitination and altered localization. Mol. Cell Biol. 23, 5331-5345 (Pubitemid 36950888)
42. Zhang, Q., Meng, Y., Zhang, L., Chen, J., and Zhu, D. (2009) RNF13: a novel RING-type ubiquitin ligase overexpressed in pancreatic cancer. Cell Res. 19, 348-357
43. Lee, H., and Tsygankov, A. Y. (2010) c-Cbl regulates glioma invasion through matrix metalloproteinase 2. J. Cell Biochem. 111, 1169-1178
44. Egeblad, M., and Werb, Z. (2002) New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2, 161-174 (Pubitemid 37328786)
45. Tsai, Y. C., Mendoza, A., Mariano, J. M., Zhou, M., Kostova, Z., Chen, B., Veenstra, T., Hewitt, S. M., Helman, L. J., Khanna, C., and Weissman, A. M. (2007) The ubiquitin ligase gp78 promotes sarcoma metastasis by targeting KAI1 for degradation. Nat. Med. 13, 1504-1509 (Pubitemid 350224250)
46. Nabi, I. R., and Raz, A. (1987) Cell shape modulation alters glycosylation of a metastatic melanoma cell surface antigen. Int. J. Cancer 40, 396-402 (Pubitemid 17156136)
47. Fang, S., Ferrone, M., Yang, C., Jensen, J. P., Tiwari, S., and Weissman, A. M. (2001) The tumor autocrine motility factor receptor, gp78, is a ubiquitin protein ligase implicated in degradation from the endoplasmic reticulum. Proc. Natl. Acad. Sci. U.S.A. 98, 14422-14427 (Pubitemid 33121407)
48. Nabi, I. R., Watanabe, H., and Raz, A. (1992) Autocrine motility factor and its receptor: role in cell locomotion and metastasis. Cancer Metastasis Rev. 11, 5-20
49. Rodríguez-Rigueiro, T., Valladares-Ayerbes, M., Haz-Conde, M., Aparicio, L. A., and Figueroa, A. (2011) Hakai reduces cell-substratum adhesion and increases epithelial cell invasion. BMC Cancer 11, 474
50. Li, D. Q., Ohshiro, K., Reddy, S. D., Pakala, S. B., Lee, M. H., Zhang, Y., Rayala, S. K., and Kumar, R. (2009) E3 ubiquitin ligase COP1 regulates the stability and functions of MTA1. Proc. Natl. Acad. Sci. U.S.A. 106, 17493-17498